Home > PE Ratio > SHUKRA PHARMACEUTICALS

SHUKRA PHARMACEUTICALS
PE (Price/Earnings) Ratio

The Current P/E Ratio of SHUKRA PHARMACEUTICALS is 27.41.

Share Price ₹116.0May 16,2024
Market Cap ₹507.9 Cr
Earnings-TTM₹18.5 CrTTM-Standalone Results
Price/Earnings27.41xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for SHUKRA PHARMACEUTICALS
Please provide your vote to see the results
SHUKRA PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks

Definition & Calculation of PE (Price/Earnings) ratio of SHUKRA PHARMACEUTICALS

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of SHUKRA PHARMACEUTICALS is calculated as :

Current Market Cap [ ₹507.9 Cr] as on May 16,2024

(/) Earnings [ ₹18.5 Cr] based on TTM-Standalone Results

(=) P/E Ratio [ 27.41x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for SHUKRA PHARMACEUTICALS , the investors are currently willing to pay 27.41 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SHUKRA PHARMACEUTICALS !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of SHUKRA PHARMACEUTICALS over the last five years.

Historical PE (Price/Earnings) ratio chart of SHUKRA PHARMACEUTICALS


PE Ratio Performance Analysis for SHUKRA PHARMACEUTICALS

- SHUKRA PHARMACEUTICALS 's latest p/e ratio is 27.41x.

- SHUKRA PHARMACEUTICALS 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 11.97x.

- SHUKRA PHARMACEUTICALS 's operated at median p/e ratio of 4.17x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, SHUKRA PHARMACEUTICALS 's p/e ratio peaked in Mar2020 at 42.79x.

- SHUKRA PHARMACEUTICALS 's p/e ratio hit its five-year low in Mar2019 of 2.58x.


How does SHUKRA PHARMACEUTICALS 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
SHUKRA PHARMACEUTICALS 18.5327.41507.9
SUN PHARMACEUTICAL INDUSTRIES LTD8,998.6340.96368,598.0
CIPLA LTD4,155.3127.59114,654.0
DR REDDYS LABORATORIES LTD5,563.2017.5197,429.4
ZYDUS LIFESCIENCES LTD2,954.2034.36101,499.0
DIVIS LABORATORIES LTD1,382.9775.45104,348.0
MANKIND PHARMA LTD1,926.5543.5183,816.9
TORRENT PHARMACEUTICALS LTD1,494.0061.2591,505.5
LUPIN LTD1,935.5739.1375,736.5
AUROBINDO PHARMA LTD2,777.8924.4767,971.8
ABBOTT INDIA LTD1,201.2246.9656,407.1

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SHUKRA PHARMACEUTICALS 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 17.51x
Max industry PE 75.45x
Median industry PE 39.13x
Average industry PE 39.87x



You may also like the below Video Courses